Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 23 Apr 2018 |
2 | Journal Copy | 20 Jul 2018 |
3 | TM-O(NOTICE OF OPPOSITION) | 25 Sep 2018 |
4 | TM-O(NOTICE OF OPPOSITION) | 25 Sep 2018 |
5 | Annexure -1 under rule 46 | 01 Mar 2019 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 01 Mar 2019 |
6 | Annexure -1 under rule 46 | 01 Mar 2019 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 01 Mar 2019 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 01 Mar 2019 |
8 | Annexure -1 under rule 46 | 01 Mar 2019 |
1 | Opposition Notice | 7048070 | 3250939 | 26 Sep 2018 |
2 | Opposition Notice | 7048092 | 3250934 | 26 Sep 2018 |
3 | Opposition Counter Statement | 7253855 | 3405239 | 12 Nov 2018 |
4 | Opposition Counter Statement | 7253957 | 3405226 | 12 Nov 2018 |
Lynzoflam was applied on 23 April 2018.
Trademark application was filed by MACKENZIE PHARMACEUTICALS.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Lynzoflam is 3814024.
Trademark attorney of the Lynzoflam is S.S. Datta & Associates.
Lynzoflam is a WORD as per IP India data.